Avantor, Inc. Stock 12‑Month Price Target Raised to $15.96, Implies 7% Downside
Avantor, Inc.'s average stock price target increased to $15.96 from $15.5, with estimates ranging from $13 to $19. This implies a 7% downside based on the Oct. 27 closing price. The consensus rating remains 'Hold' among 18 analysts.
How this was made

The 30-second read
Why it matters
Analyst price target adjustments can influence short-term trading sentiment but are unlikely to drive large price moves without additional catalysts.
Market read
The price target update offers modest insight for traders but lacks a strong actionable catalyst.
What to watch
Potential upcoming product launches or contract wins not reflected in the current analyst consensus.
Background
Avantor is a global provider of chemicals and services to the life sciences and advanced technologies markets.
Ticker impact
Analyst consensus price target raised to $15.96, implying ~7% downside from the current price.
potential downside pressure as the market prices in the lower upside potential
Price target change is small and the consensus rating remains Hold, indicating no strong catalyst for a move.
Market effects
Minor impact on specialty chemicals sector as analysts adjust expectations for Avantor.
Limited to US-listed specialty chemicals investors.
Low global relevance.
Counterpoint
Investors may view the target raise as a sign of underlying strength despite the implied downside.
Key entities
- CompanyAvantor, Inc.
Specialty chemicals and life sciences services provider.


